International Clinical Trial: A Trial of ONO-2808 in Participants With the Parkinsonian Subtype of Multiple System Atrophy (MSA-P)

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07825402) titled 'A Trial of ONO-2808 in Participants With the Parkinsonian Subtype of Multiple System Atrophy (MSA-P)' on Sept. 13.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).

Primary Sponsor: Ono Pharmaceutical Co., Ltd.

Condition: Multiple System Atrophy, Parkinson Variant

Intervention: Drug: ONO-2808

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: January 2027

Target Sample Size: 486

To know more, visit https://clinicaltrials.gov/study/NCT07825402

Publis...